{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:05:12Z","timestamp":1788537912326,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,30]]},"DOI":"10.7759\/cureus.70501","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T11:58:25Z","timestamp":1727697505000},"source":"Crossref","is-referenced-by-count":5,"title":["Available Treatments and Adjunctive Therapies for Polycystic Ovarian Syndrome (PCOS) Patients of Reproductive Age: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Lisa","family":"Cochran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Nadolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A","family":"Kluglein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Yagoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Dressel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Prol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Shipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M","family":"Costin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-011-0130-0","article-title":"Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease","volume":"13","author":"McGowan MP","year":"2011","unstructured":"McGowan MP. Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease. Curr Treat Options Cardiovasc Med. 2011, 13:289-301. 10.1007\/s11936-011-0130-0","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref2","unstructured":"Polycystic ovary syndrome. (2023). https.\/\/www.who.int\/news-room\/fact-sheets\/detail\/polycystic-ovary-syndrome."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mefs.2017.05.007","article-title":"An epidemiological survey: effect of predisposing factors for PCOS in Indian urban and rural population","volume":"22","author":"Bharathi RV","year":"2017","unstructured":"Bharathi RV, Swetha S, Neerajaa J, et al.. An epidemiological survey: effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J. 2017, 22:313-6. 10.1016\/j.mefs.2017.05.007","journal-title":"Middle East Fertil Soc J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras A","year":"2017","unstructured":"Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril. 2017, 107:1380-6.. 10.1016\/j.fertnstert.2017.04.011","journal-title":"Fertil Steril"},{"key":"ref5","article-title":"Polycystic ovarian disease","author":"Rasquin LI","year":"2022","unstructured":"Rasquin LI, Anastasopoulou C, Mayrin JV. Polycystic ovarian disease. StatPearls. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2963","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm M","year":"2017","unstructured":"Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017, 102:604-12. 10.1210\/jc.2016-2963","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmu028","article-title":"Women's experiences of polycystic ovary syndrome diagnosis","volume":"31","author":"Gibson-Helm ME","year":"2014","unstructured":"Gibson-Helm ME, Lucas IM, Boyle JA, Teede HJ. Women's experiences of polycystic ovary syndrome diagnosis. Fam Pract. 2014, 31:545-9. 10.1093\/fampra\/cmu028","journal-title":"Fam Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel S","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018, 182:27-36. 10.1016\/j.jsbmb.2018.04.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","volume":"102","author":"Daan NM","year":"2014","unstructured":"Daan NM, Louwers YV, Koster MP, et al.. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?. Fertil Steril. 2014, 102:1444-51. 10.1016\/j.fertnstert.2014.08.001","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2014.04.15","article-title":"Metformin use in women with polycystic ovary syndrome","volume":"2","author":"Johnson NP","year":"2014","unstructured":"Johnson NP. Metformin use in women with polycystic ovary syndrome. Ann Transl Med. 2014, 2:56. 10.3978\/j.issn.2305-5839.2014.04.15","journal-title":"Ann Transl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1586\/eem.10.88","article-title":"Oral contraceptives in polycystic ovarian syndrome: the long and short of it","volume":"6","author":"Nader S","year":"2011","unstructured":"Nader S. Oral contraceptives in polycystic ovarian syndrome: the long and short of it. Expert Rev Endocrinol Metab. 2011, 6:129-33. 10.1586\/eem.10.88","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2021.1958310","article-title":"Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments","volume":"37","author":"Coll\u00e9e J","year":"2021","unstructured":"Coll\u00e9e J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol. 2021, 37:869-74. 10.1080\/09513590.2021.1958310","journal-title":"Gynecol Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.7.4919","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani B","year":"1998","unstructured":"Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab. 1998, 83:2361-5. 10.1210\/jcem.83.7.4919","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(02)02725-4","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz R","year":"2003","unstructured":"Azziz R. The evaluation and management of hirsutism. Obstet Gynecol. 2003, 101:995-1007. 10.1016\/s0029-7844(02)02725-4","journal-title":"Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1896","article-title":"Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS","volume":"101","author":"Dokras A","year":"2016","unstructured":"Dokras A, Sarwer DB, Allison KC, et al.. Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. J Clin Endocrinol Metab. 2016, 101:2966-74. 10.1210\/jc.2016-1896","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","article-title":"Evaluation and treatment of polycystic ovary syndrome","author":"Legro RS","year":"2017","unstructured":"Legro RS. Evaluation and treatment of polycystic ovary syndrome. Endotext. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, South Dartmouth, MA; 2017."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1586\/17446651.3.3.349","article-title":"Treatment for polycystic ovary syndrome: a critical appraisal of treatment options","volume":"3","author":"Nader S","year":"2008","unstructured":"Nader S. Treatment for polycystic ovary syndrome: a critical appraisal of treatment options. Expert Rev Endocrinol Metab. 2008, 3:349-59. 10.1586\/17446651.3.3.349","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/59380","article-title":"The pathogenesis and treatment of polycystic ovary syndrome: what's new?","volume":"26","author":"Bednarska S","year":"2017","unstructured":"Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what's new?. Adv Clin Exp Med. 2017, 26:359-67. 10.17219\/acem\/59380","journal-title":"Adv Clin Exp Med"},{"key":"ref19","unstructured":"Resources, Scoping Review Network. (2024). https.\/\/jbi.global\/scoping-review-network\/resources."},{"key":"ref20","unstructured":"Critical Appraisal Tools. (2024). https.\/\/jbi.global\/critical-appraisal-tools."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab320","article-title":"Randomized controlled trial of neurokinin 3 receptor antagonist fezolinetant for treatment of polycystic ovary syndrome","volume":"106","author":"Fraser GL","year":"2021","unstructured":"Fraser GL, Obermayer-Pietsch B, Laven J, et al.. Randomized controlled trial of neurokinin 3 receptor antagonist fezolinetant for treatment of polycystic ovary syndrome. J Clin Endocrinol Metab. 2021, 106:e3519-32. 10.1210\/clinem\/dgab320","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2018.04.015","article-title":"The effects of different therapeutic modalities on cardiovascular risk factors in women with polycyst\u0131c ovary syndrome: a random\u0131zed controlled study","volume":"57","author":"Bodur S","year":"2018","unstructured":"Bodur S, Dundar O, Kanat-Pektas M, Kinci MF, Tutuncu L. The effects of different therapeutic modalities on cardiovascular risk factors in women with polycyst\u0131c ovary syndrome: a random\u0131zed controlled study. Taiwan J Obstet Gynecol. 2018, 57:411-6. 10.1016\/j.tjog.2018.04.015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13310","article-title":"Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome","volume":"86","author":"Dokras A","year":"2017","unstructured":"Dokras A, Playford M, Kris-Etherton PM, et al.. Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2017, 86:739-46. 10.1111\/cen.13310","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.179783","article-title":"Comparison of drospirenone- with cyproterone acetate-containing oral contraceptives, combined with metformin and lifestyle modifications in women with polycystic ovary syndrome and metabolic disorders: a prospective randomized control trial","volume":"129","author":"Wang QY","year":"2016","unstructured":"Wang QY, Song Y, Huang W, Xiao L, Wang QS, Feng GM. Comparison of drospirenone- with cyproterone acetate-containing oral contraceptives, combined with metformin and lifestyle modifications in women with polycystic ovary syndrome and metabolic disorders: a prospective randomized control trial. Chin Med J (Engl). 2016, 129:883-90. 10.4103\/0366-6999.179783","journal-title":"Chin Med J (Engl)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex227","article-title":"Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome","volume":"32","author":"Amer SA","year":"2017","unstructured":"Amer SA, Smith J, Mahran A, Fox P, Fakis A. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod. 2017, 32:1631-8. 10.1093\/humrep\/dex227","journal-title":"Hum Reprod"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20180039","article-title":"Evaluation of pretreatment with Cetrotide in an antagonist protocol for patients with PCOS undergoing IVF\/ICSI cycles: a randomized clinical trial","volume":"22","author":"Eftekhar M","year":"2018","unstructured":"Eftekhar M, Bagheri RB, Neghab N, Hosseinisadat R. Evaluation of pretreatment with Cetrotide in an antagonist protocol for patients with PCOS undergoing IVF\/ICSI cycles: a randomized clinical trial. JBRA Assist Reprod. 2018, 22:238-43. 10.5935\/1518-0557.20180039","journal-title":"JBRA Assist Reprod"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00677-x","article-title":"Growth hormone activates PI3K\/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome","volume":"18","author":"Gong Y","year":"2020","unstructured":"Gong Y, Luo S, Fan P, Zhu H, Li Y, Huang W. Growth hormone activates PI3K\/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2020, 18:121. 10.1186\/s12958-020-00677-x","journal-title":"Reprod Biol Endocrinol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S83259","article-title":"Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study","volume":"9","author":"Xi W","year":"2015","unstructured":"Xi W, Liu S, Mao H, Yang Y, Xue X, Lu X. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study. Drug Des Devel Ther. 2015, 9:6001-8. 10.2147\/DDDT.S83259","journal-title":"Drug Des Devel Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.04.027","article-title":"Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study","volume":"118","author":"Elkind-Hirsch KE","year":"2022","unstructured":"Elkind-Hirsch KE, Chappell N, Shaler D, Storment J, Bellanger D. Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study. Fertil Steril. 2022, 118:371-81. 10.1016\/j.fertnstert.2022.04.027","journal-title":"Fertil Steril"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-016-0520-9","article-title":"Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome","volume":"14","author":"Ou HT","year":"2016","unstructured":"Ou HT, Chen PC, Wu MH, Lin CY. Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome. Health Qual Life Outcomes. 2016, 14:119. 10.1186\/s12955-016-0520-9","journal-title":"Health Qual Life Outcomes"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3050487","article-title":"Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study","volume":"2020","author":"Guo QJ","year":"2020","unstructured":"Guo QJ, Shan J, Xu YF, et al.. Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study. Mediators Inflamm. 2020, 2020:3050487. 10.1155\/2020\/3050487","journal-title":"Mediators Inflamm"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-015-0005-6","article-title":"The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls","volume":"15","author":"Kahal H","year":"2015","unstructured":"Kahal H, Aburima A, Ungvari T, et al.. The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls. BMC Endocr Disord. 2015, 15:14. 10.1186\/s12902-015-0005-6","journal-title":"BMC Endocr Disord"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz028","article-title":"Sitagliptin decreases visceral fat and blood glucose in women with polycystic ovarian syndrome","volume":"105","author":"Devin JK","year":"2020","unstructured":"Devin JK, Nian H, Celedonio JE, Wright P, Brown NJ. Sitagliptin decreases visceral fat and blood glucose in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2020, 105:136-51. 10.1210\/clinem\/dgz028","journal-title":"J Clin Endocrinol Metab"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001712","article-title":"Short-term combined treatment with exenatide and metformin for overweight\/obese women with polycystic ovary syndrome","volume":"134","author":"Ma RL","year":"2021","unstructured":"Ma RL, Deng Y, Wang YF, Zhu SY, Ding XS, Sun AJ. Short-term combined treatment with exenatide and metformin for overweight\/obese women with polycystic ovary syndrome. Chin Med J (Engl). 2021, 134:2882-9. 10.1097\/CM9.0000000000001712","journal-title":"Chin Med J (Engl)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1089\/met.2016.0009","article-title":"Pioglitazone therapy increases insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome","volume":"14","author":"Gupta A","year":"2016","unstructured":"Gupta A, Jakubowicz D, Nestler JE. Pioglitazone therapy increases insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. Metab Syndr Relat Disord. 2016, 14:391-6. 10.1089\/met.2016.0009","journal-title":"Metab Syndr Relat Disord"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.06.015","article-title":"Effect of metformin on microvascular endothelial function in polycystic ovary syndrome","volume":"94","author":"Heidari B","year":"2019","unstructured":"Heidari B, Lerman A, Lalia AZ, Lerman LO, Chang AY. Effect of metformin on microvascular endothelial function in polycystic ovary syndrome. Mayo Clin Proc. 2019, 94:2455-66. 10.1016\/j.mayocp.2019.06.015","journal-title":"Mayo Clin Proc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa692","article-title":"Exenatide, metformin, or both for prediabetes in PCOS: a randomized, open-label, parallel-group controlled study","volume":"106","author":"Tao T","year":"2021","unstructured":"Tao T, Zhang Y, Zhu YC, et al.. Exenatide, metformin, or both for prediabetes in PCOS: a randomized, open-label, parallel-group controlled study. J Clin Endocrinol Metab. 2021, 106:e1420-32. 10.1210\/clinem\/dgaa692","journal-title":"J Clin Endocrinol Metab"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1648-7","article-title":"The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial","volume":"58","author":"Gholizadeh Shamasbi S","year":"2019","unstructured":"Gholizadeh Shamasbi S, Dehgan P, Mohammad-Alizadeh Charandabi S, Aliasgarzadeh A, Mirghafourvand M. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Eur J Nutr. 2019, 58:629-40. 10.1007\/s00394-018-1648-7","journal-title":"Eur J Nutr"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05194-w","article-title":"The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial","volume":"300","author":"Hager M","year":"2019","unstructured":"Hager M, Nouri K, Imhof M, Egarter C, Ott J. The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial. Arch Gynecol Obstet. 2019, 300:455-60. 10.1007\/s00404-019-05194-w","journal-title":"Arch Gynecol Obstet"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026049","article-title":"Therapeutic effects of puerarin on polycystic ovary syndrome: a randomized trial in Chinese women","volume":"100","author":"Li W","year":"2021","unstructured":"Li W, Hu H, Zou G, Ma Z, Liu J, Li F. Therapeutic effects of puerarin on polycystic ovary syndrome: a randomized trial in Chinese women. Medicine (Baltimore). 2021, 100:e26049. 10.1097\/MD.0000000000026049","journal-title":"Medicine (Baltimore)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202104_25743","article-title":"A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients","volume":"25","author":"Hernandez Marin I","year":"2021","unstructured":"Hernandez Marin I, Picconi O, Lagan\u00e0 AS, Costabile L, Unfer V. A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients. Eur Rev Med Pharmacol Sci. 2021, 25:3316-24. 10.26355\/eurrev_202104_25743","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/nu9121280","article-title":"Effect of two different doses of vitamin D supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome12","volume":"9","author":"Jamilian M","year":"2017","unstructured":"Jamilian M, Foroozanfard F, Rahmani E, Talebi M, Bahmani F, Asemi Z. Effect of two different doses of vitamin D supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome12. Nutrients. 2017, 9:80. 10.3390\/nu9121280","journal-title":"Nutrients"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-018-0457-1","article-title":"The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome","volume":"11","author":"Jamilian M","year":"2018","unstructured":"Jamilian M, Mansury S, Bahmani F, Heidar Z, Amirani E, Asemi Z. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. J Ovarian Res. 2018, 11:80. 10.1186\/s13048-018-0457-1","journal-title":"J Ovarian Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0480-x","article-title":"Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome","volume":"12","author":"Ostadmohammadi V","year":"2019","unstructured":"Ostadmohammadi V, Jamilian M, Bahmani F, Asemi Z. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. J Ovarian Res. 2019, 12:5. 10.1186\/s13048-019-0480-x","journal-title":"J Ovarian Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-020-0524-5","article-title":"The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial","volume":"19","author":"Haidari F","year":"2020","unstructured":"Haidari F, Banaei-Jahromi N, Zakerkish M, Ahmadi K. The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial. Nutr J. 2020, 19:8. 10.1186\/s12937-020-0524-5","journal-title":"Nutr J"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.6133\/apjcn.062017.13","article-title":"Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome","volume":"27","author":"Borzoei A","year":"2018","unstructured":"Borzoei A, Rafraf M, Asghari-Jafarabadi M. Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome. Asia Pac J Clin Nutr. 2018, 27:556-63. 10.6133\/apjcn.062017.13","journal-title":"Asia Pac J Clin Nutr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-020-00601-4","article-title":"The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"19","author":"Tabrizi FP","year":"2020","unstructured":"Tabrizi FP, Farhangi MA, Vaezi M, Hemmati S. The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Nutr J. 2020, 19:82. 10.1186\/s12937-020-00601-4","journal-title":"Nutr J"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010188","article-title":"A randomized, controlled trial of vitamin D supplementation on cardiovascular risk factors, hormones, and liver markers in women with polycystic ovary syndrome","volume":"11","author":"Javed Z","year":"2019","unstructured":"Javed Z, Papageorgiou M, Deshmukh H, et al.. A randomized, controlled trial of vitamin D supplementation on cardiovascular risk factors, hormones, and liver markers in women with polycystic ovary syndrome. Nutrients. 2019, 11:188. 10.3390\/nu11010188","journal-title":"Nutrients"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1760-8","article-title":"Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial","volume":"58","author":"Trummer C","year":"2019","unstructured":"Trummer C, Schwetz V, Kollmann M, et al.. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial. Eur J Nutr. 2019, 58:2019-28. 10.1007\/s00394-018-1760-8","journal-title":"Eur J Nutr"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-021-01223-3","article-title":"Green cardamom plus low-calorie diet can decrease the expression of inflammatory genes among obese women with polycystic ovary syndrome: a double-blind randomized clinical trial","volume":"27","author":"Cheshmeh S","year":"2022","unstructured":"Cheshmeh S, Ghayyem M, Khamooshi F, et al.. Green cardamom plus low-calorie diet can decrease the expression of inflammatory genes among obese women with polycystic ovary syndrome: a double-blind randomized clinical trial. Eat Weight Disord. 2022, 27:821-30. 10.1007\/s40519-021-01223-3","journal-title":"Eat Weight Disord"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-019-01461-6","article-title":"Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial","volume":"36","author":"Bahramrezaie M","year":"2019","unstructured":"Bahramrezaie M, Amidi F, Aleyasin A, et al.. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. J Assist Reprod Genet. 2019, 36:1701-12. 10.1007\/s10815-019-01461-6","journal-title":"J Assist Reprod Genet"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0248-0","article-title":"The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"18","author":"Nasri K","year":"2018","unstructured":"Nasri K, Jamilian M, Rahmani E, Bahmani F, Tajabadi-Ebrahimi M, Asemi Z. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC Endocr Disord. 2018, 18:21. 10.1186\/s12902-018-0248-0","journal-title":"BMC Endocr Disord"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.5858","article-title":"Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): a randomized controlled trial","volume":"31","author":"Arentz S","year":"2017","unstructured":"Arentz S, Smith CA, Abbott J, Fahey P, Cheema BS, Bensoussan A. Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): a randomized controlled trial. Phytother Res. 2017, 31:1330-40. 10.1002\/ptr.5858","journal-title":"Phytother Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01955-z","article-title":"Probiotic effects on sexual function in women with polycystic ovary syndrome: a double blinded randomized controlled trial","volume":"22","author":"Azizi-Kutenaee M","year":"2022","unstructured":"Azizi-Kutenaee M, Heidari S, Taghavi SA, Bazarganipour F. Probiotic effects on sexual function in women with polycystic ovary syndrome: a double blinded randomized controlled trial. BMC Womens Health. 2022, 22:373. 10.1186\/s12905-022-01955-z","journal-title":"BMC Womens Health"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01825-8","article-title":"Effect of vitamin K2 administration on depression status in patients with polycystic ovary syndrome: a randomized clinical trial","volume":"22","author":"Tarkesh F","year":"2022","unstructured":"Tarkesh F, Namavar Jahromi B, Hejazi N, Hoseini G. Effect of vitamin K2 administration on depression status in patients with polycystic ovary syndrome: a randomized clinical trial. BMC Womens Health. 2022, 22:315. 10.1186\/s12905-022-01825-8","journal-title":"BMC Womens Health"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-022-00982-7","article-title":"The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial","volume":"20","author":"Jaripur M","year":"2022","unstructured":"Jaripur M, Ghasemi-Tehrani H, Askari G, Gholizadeh-Moghaddam M, Clark CC, Rouhani MH. The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial. Reprod Biol Endocrinol. 2022, 20:110. 10.1186\/s12958-022-00982-7","journal-title":"Reprod Biol Endocrinol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0554-9","article-title":"Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial","volume":"12","author":"Behboudi-Gandevani S","year":"2019","unstructured":"Behboudi-Gandevani S, Abtahi H, Saadat N, Tohidi M, Ramezani Tehrani F. Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial. J Ovarian Res. 2019, 12:78. 10.1186\/s13048-019-0554-9","journal-title":"J Ovarian Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2020.051","article-title":"Weekly osteopathic manipulative treatment to improve measures of sympathetic tone in women with polycystic ovary syndrome: a randomized, controlled pilot study","volume":"120","author":"Davis SE","year":"2020","unstructured":"Davis SE, Hendryx J, Menezes C, et al.. Weekly osteopathic manipulative treatment to improve measures of sympathetic tone in women with polycystic ovary syndrome: a randomized, controlled pilot study. J Am Osteopath Assoc. 2020, 120:310-21. 10.7556\/jaoa.2020.051","journal-title":"J Am Osteopath Assoc"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12571","article-title":"Serum anti-M\u00fcllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial","volume":"94","author":"Leonhardt H","year":"2015","unstructured":"Leonhardt H, Hellstr\u00f6m M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E. Serum anti-M\u00fcllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial. Acta Obstet Gynecol Scand. 2015, 94:279-87. 10.1111\/aogs.12571","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01861-4","article-title":"A randomised controlled trial on the effects of a structural education module among women with polycystic ovarian syndrome on nutrition and physical activity changes","volume":"22","author":"Dashti S","year":"2022","unstructured":"Dashti S, Abdul Hamid H, Mohamad Saini S, et al.. A randomised controlled trial on the effects of a structural education module among women with polycystic ovarian syndrome on nutrition and physical activity changes. BMC Womens Health. 2022, 22:277. 10.1186\/s12905-022-01861-4","journal-title":"BMC Womens Health"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.03.028","article-title":"Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial","volume":"110","author":"Cooney LG","year":"2018","unstructured":"Cooney LG, Milman LW, Hantsoo L, et al.. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial. Fertil Steril. 2018, 110:161-71. 10.1016\/j.fertnstert.2018.03.028","journal-title":"Fertil Steril"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000000879","article-title":"Vitamin D and polycystic ovary syndrome (PCOS): a review","volume":"85","author":"Mohan A","year":"2023","unstructured":"Mohan A, Haider R, Fakhor H, et al.. Vitamin D and polycystic ovary syndrome (PCOS): a review. Ann Med Surg (Lond). 2023, 85:3506-11. 10.1097\/MS9.0000000000000879","journal-title":"Ann Med Surg (Lond)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2017.09.11","article-title":"Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies","volume":"6","author":"Kamboj MK","year":"2017","unstructured":"Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Transl Pediatr. 2017, 6:248-55. 10.21037\/tp.2017.09.11","journal-title":"Transl Pediatr"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02329-y","article-title":"Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review","volume":"47","author":"Pinto J","year":"2024","unstructured":"Pinto J, Cera N, Pignatelli D. Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review. J Endocrinol Invest. 2024, 47:1-22. 10.1007\/s40618-024-02329-y","journal-title":"J Endocrinol Invest"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1667310","article-title":"Integrated model of care for polycystic ovary syndrome","volume":"36","author":"Tay CT","year":"2018","unstructured":"Tay CT, Moran LJ, Wijeyaratne CN, Redman LM, Norman RJ, Teede HJ, Joham AE. Integrated model of care for polycystic ovary syndrome. Semin Reprod Med. 2018, 36:86-94. 10.1055\/s-0038-1667310","journal-title":"Semin Reprod Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/292371-available-treatments-and-adjunctive-therapies-for-polycystic-ovarian-syndrome-pcos-patients-of-reproductive-age-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T11:58:33Z","timestamp":1727697513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/292371-available-treatments-and-adjunctive-therapies-for-polycystic-ovarian-syndrome-pcos-patients-of-reproductive-age-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":65,"URL":"https:\/\/doi.org\/10.7759\/cureus.70501","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}